• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

界定卫生技术评估的范围及卫生经济评估的类型。

Defining the scope of health technology assessment and types of health economic evaluation.

作者信息

Tanvejsilp Pimwara, Ngorsuraches Surachat

出版信息

J Med Assoc Thai. 2014 May;97 Suppl 5:S10-6.

PMID:24964694
Abstract

Health Technology Assessment (HTA) is a process that uses principles from across various disciplines, including medicine, sociology, economics, and ethics, to evaluate health technologies. Policy makers can use HTA as a tool to assess health technologies in a systematic, unbiased, transparent, and robust manner in order to make informed and evidence-based decisions. Generally, researchers begin an HTA by defining the overall scope of the assessment, after which they choose an appropriate type of health economic evaluation, one of the most important elements of HTA. The objective of this article is to provide recommendations about the scope of HTA as well as guidance on the kinds of health economic evaluation that are appropriate in the context of the new Thai HTA guidelines. A well-defined research question that addresses five major components-target population, technology or intervention, comparator outcome of interest, and perspective-is an essential

摘要

卫生技术评估(HTA)是一个运用包括医学、社会学、经济学和伦理学等多学科原理来评估卫生技术的过程。政策制定者可以将HTA作为一种工具,以系统、公正、透明和稳健的方式评估卫生技术,从而做出明智且基于证据的决策。通常,研究人员开展卫生技术评估时首先要界定评估的总体范围,之后选择合适的卫生经济评估类型,这是卫生技术评估最重要的要素之一。本文的目的是就卫生技术评估的范围提供建议,并针对符合泰国新卫生技术评估指南背景下适用的卫生经济评估类型提供指导。一个明确界定的、涉及五个主要组成部分——目标人群、技术或干预措施、对照、感兴趣的结果以及视角——的研究问题至关重要。

相似文献

1
Defining the scope of health technology assessment and types of health economic evaluation.界定卫生技术评估的范围及卫生经济评估的类型。
J Med Assoc Thai. 2014 May;97 Suppl 5:S10-6.
2
Budget impact analysis.预算影响分析。
J Med Assoc Thai. 2014 May;97 Suppl 5:S65-71.
3
Application of HTA research on policy decision-making.卫生技术评估研究在政策决策中的应用。
J Med Assoc Thai. 2014 May;97 Suppl 5:S119-26.
4
Defining types of economic evaluation.定义经济评估的类型。
J Med Assoc Thai. 2008 Jun;91 Suppl 2:S21-7.
5
Guidelines for health technology assessment in Thailand (second edition)--the development process.泰国卫生技术评估指南(第二版)——制定过程
J Med Assoc Thai. 2014 May;97 Suppl 5:S4-9.
6
Presentation of economic evaluation results.经济评估结果的呈现。
J Med Assoc Thai. 2014 May;97 Suppl 5:S72-80.
7
Thai health technology assessment guideline development.泰国卫生技术评估指南的制定。
J Med Assoc Thai. 2008 Jun;91 Suppl 2:S11-5.
8
Historical development of health technology assessment in Thailand.泰国卫生技术评估的历史发展
Int J Technol Assess Health Care. 2009 Jul;25 Suppl 1:241-52. doi: 10.1017/S0266462309090709. Epub 2009 Jun 16.
9
A determination of topics for health technology assessment in Thailand: making decision makers involved.泰国卫生技术评估主题的确定:让决策者参与其中。
J Med Assoc Thai. 2008 Jun;91 Suppl 2:S100-9.
10
Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.避免和识别健康技术评估模型中的错误:定性研究和方法学综述。
Health Technol Assess. 2010 May;14(25):iii-iv, ix-xii, 1-107. doi: 10.3310/hta14250.

引用本文的文献

1
Cost-Utility Analysis of Dapagliflozin as an Add-on to Standard of Care for Patients with Chronic Kidney Disease in Thailand.达格列净添加至泰国慢性肾脏病患者标准治疗的成本效用分析。
Adv Ther. 2022 Mar;39(3):1279-1292. doi: 10.1007/s12325-021-02037-6. Epub 2022 Jan 17.
2
Cost-Utility Analysis of Sacubitril-Valsartan Compared with Enalapril Treatment in Patients with Acute Decompensated Heart Failure in Thailand.泰国急性失代偿性心力衰竭患者中沙库巴曲缬沙坦与依那普利治疗的成本-效用分析。
Clin Drug Investig. 2021 Oct;41(10):907-915. doi: 10.1007/s40261-021-01079-6. Epub 2021 Sep 17.
3
A comparison of cost and cost-effectiveness analysis of two- implant-retained overdentures versus other removable prosthodontic treatment options for edentulous mandible: A systematic review.
下颌无牙颌患者使用两颗种植体支持的覆盖义齿与其他可摘义齿修复治疗方案的成本及成本效益分析比较:一项系统评价
J Indian Prosthodont Soc. 2020 Apr-Jun;20(2):162-170. doi: 10.4103/jips.jips_393_19. Epub 2020 Apr 7.
4
Cost-Effectiveness Analysis of the Adjunctive Therapy of Ivabradine for the Treatment of Heart Failure with Reduced Ejection Fraction.伊伐布雷定辅助治疗射血分数降低的心力衰竭的成本效益分析
Clinicoecon Outcomes Res. 2019 Dec 5;11:767-777. doi: 10.2147/CEOR.S226568. eCollection 2019.
5
Rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. Who decides? Who pays?卫生技术评估及其他全球和国家卫生投资经济评估中的不同观点。谁来决定?谁来支付?
F1000Res. 2018 Jan 17;7:72. doi: 10.12688/f1000research.13284.1. eCollection 2018.
6
The cost utility and budget impact of adjuvant racecadotril for acute diarrhea in children in Thailand.泰国儿童急性腹泻使用辅助消旋卡多曲的成本效用及预算影响
Clinicoecon Outcomes Res. 2017 Jul 17;9:411-422. doi: 10.2147/CEOR.S140902. eCollection 2017.
7
Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy in elderly type 2 diabetes patients in Thailand.二肽基肽酶-4抑制剂单药治疗在泰国老年2型糖尿病患者中的成本效益
Clinicoecon Outcomes Res. 2016 Sep 21;8:521-529. doi: 10.2147/CEOR.S113559. eCollection 2016.
8
Willingness to pay per quality-adjusted life year for life-saving treatments in Thailand.泰国为挽救生命的治疗所支付的每质量调整生命年的意愿。
BMJ Open. 2015 Oct 5;5(10):e008123. doi: 10.1136/bmjopen-2015-008123.